Trial Details
RECRUITINGBasic Information
| Clinical ID | c750 |
|---|---|
| Identifier | NCT06113913 |
| Trial Title | Subcutaneous Infliximab After A Previous Intravenous Dose Optimization |
| Trial URL | Visit Original Page |
Study Information
| Study Results | NO |
|---|---|
| Conditions | Inflammatory Bowel Diseases|Crohn Disease|Ulcerative Colitis |
| Interventions | DRUG: Infliximab|DRUG: Infliximab|DRUG: Infliximab |
Participant Information
| Sponsor | Belgian Inflammatory Bowel Disease Research and Development (BIRD) VZW |
|---|---|
| City | Oost-Vlaanderen |
| Country/Region | Belgium |
Enrollment Criteria
| Sex Requirement | ALL |
|---|---|
| Age Requirement | ADULT, OLDER_ADULT |
Study Design
| Study Type | INTERVENTIONAL |
|---|---|
| Phase | PHASE4 |
Time Information
| Start Date | 2024-04-09 |
|---|---|
| Primary Completion Date | 2026-05 |
| Completion Date | 2026-11 |